A new study shows that a simple nutrition care program can improve nutritional status, physical functionality, cognitive function, and psychological well-being in older adults. The program reduced hospitalizations by 40% and associated costs.
A new study published in Nutrients highlights the importance of adequate protein intake for adults living with diabetes. The research found that nearly half of US adults with diabetes did not meet the daily recommended protein intake, leading to greater physical limitations and potentially increasing the risk of muscle loss.
The study shows that the FreeStyle Libre 14 day system is estimated to save roughly 50% in average costs associated with severe hypoglycemia for people with type 1 and type 2 diabetes. Annual cost savings are 61% and 63% lower compared to traditional fingerstick testing.
A recent study reveals that nearly half of infectious disease and long-term care patients, as well as over 40% of oncology patients, are at risk of malnutrition. Malnutrition can increase patients' risk of complications and delay recovery, emphasizing the need for nutrition care in hospitals.
A comprehensive review confirms low muscle mass is linked to increased risk of serious health complications and decreased survival. Muscle mass should be considered a key factor in evaluating a person's health status, especially if living with a chronic disease.
A new study published in The Journal of Parenteral and Enteral Nutrition found that a nutrition care program significantly reduced readmission rates for malnourished surgical patients. The program resulted in a nearly 50% reduction in hospital readmissions and a 2.7-day shorter average length of stay.
Pfizer announces new scientific abstracts and presentations for XELJANZ (tofacitinib citrate) in rheumatoid arthritis, including safety data, long-term extension studies, and real-world evaluation. The data highlights the efficacy and safety of XELJANZ in treating RA.
A recent survey found that nearly two-thirds of employees who have been diagnosed with depression reported challenges related to thinking on the job, resulting in reduced productivity. The Right Direction initiative aims to increase awareness of depression in the workplace and provide resources for employers to support their employees.
A post-hoc analysis of patients with type 2 diabetes found that intensification of insulin therapy with Januvia (sitagliptin) 100 mg once-daily resulted in lower incidence of nighttime hypoglycemia compared to placebo. This is a positive finding for treatment approaches aimed at lowering nocturnal hypoglycemia.
A retrospective cohort study found patients taking JANUVIA and metformin initiated insulin therapy at a slower rate than those taking a sulfonylurea and metformin. The study suggests that real-world data may provide insight into the effects of different oral treatment regimens on the initiation of insulin use.
A post-hoc analysis found that patients with Type 2 diabetes and mild renal impairment treated with JANUVIA achieved similar blood sugar reductions as those treated with sulfonylureas, with significantly fewer hypoglycemia events. Patients taking JANUVIA also experienced weight loss, whereas those on sulfonylureas gained weight.